Liquidia Corporation Common Stock vs StoneX Group Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $34.17 (market cap $2.40B), while StoneX Group Inc. Common Stock trades at $59.51 (market cap $7.27B). The key difference: StoneX Group Inc. Common Stock is far larger — about 3× Liquidia Corporation Common Stock's market cap, and StoneX Group Inc. Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and StoneX Group Inc. Common Stock for 0 Days on average.
| LQDA | SNEX | |
|---|---|---|
Market Cap | $2.40B | $7.27B |
Volume | 2,857,547 | 1,624,795 |
Sector | Health | Financials |
52-Week High | $91.03 | $92.67 |
52-Week Low | $22.02 | $37.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.30B | $28.28B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →StoneX Group Inc. is a financial services firm providing trading, clearing, execution, and cross-border payment services to institutional, commercial, and self-directed retail clients across global markets.
Read more on SNEX →